A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC)
Status:
Terminated
Trial end date:
2019-01-31
Target enrollment:
Participant gender:
Summary
This is a research trial testing DUR-928 (an experimental medication). The purpose of the
trial is to assess whether treatment with DUR-928 has any effect on the treatment of Primary
Sclerosing Cholangitis (PSC). This trial will also assess safety (side effects).